Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections

Retina

Volumn 30, Issue 2, 2010, Pages 203-211

  Chan, Clement K ^a,b   Abraham, Prema ^c   Meyer, Carsten H ^d   Kokame, Gregg T ^e,f   Kaiser, Peter K ^g   Rauser, Michael E ^b   Gross, Jeffrey G ^h   Nuthi, Asha S D ^a   Lin, Steven G ^a   Daher, Noha S ^b  

^a Southern California Desert Retina Consultants   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

^c Black Hills Regional Eye Institute   (United States)

^d UNIVERSITY HOSPITAL BONN   (Germany)

^e Retina Center at Pali Momi   (United States)

^f UNIVERSITY OF HAWAII   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h Carolina Retina Center   (United States)

Author keywords

Avastin; Bevacizumab; Fibrovascular pigment epithelial detachment; Intravitreal injection; Optical coherence tomography; Retinal pigment epithelial detachment; Retinal pigment epithelial height; Retinal pigment epithelial rip; Retinal pigment epithelial tear

Indexed keywords

BEVACIZUMAB;

AGED; ANTIANGIOGENIC THERAPY; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OPTICAL COHERENCE TOMOGRAPHY; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA CYSTOID EDEMA; RETINA MACULA LUTEA; RETINA TEAR; RISK ASSESSMENT; RISK FACTOR; SUBRETINAL FLUID; THICKNESS; TISSUE STRUCTURE; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS; MACULAR DEGENERATION; MALE; RETINAL DETACHMENT; RETINAL PERFORATIONS; RETINAL PIGMENT EPITHELIUM; RETROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 76749105221     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181babda5     Document Type: Article

References (44)

1. Hoskin A, Bird AC, Sehmi K. Tears of detached retinal pigment epithelium. Br J Ophthalmol 1981;65:417-422.
2. Gass JD. Pathogenesis of tears of the retinal pigment epithelium. Br J Ophthalmol 1984;68:513-519.
3. Gass JD. Serous retinal pigment epithelium with a notch: a sign of choroidal neovascularization. Retina 1984;4:205-220.
4. Cantrill HL, Ramsay RC, Knobloch WH. Rips in the pigment epithelium. Arch Ophthalmol 1983;101:1074-1079.
5. Casswell AG, Kohen D, Bird AC. Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol 1985;69:397-403.
6. Chuang EL, Bird AC. Repair after tears of the retinal pigment epithelium. Eye 1988;2:106-113.
7. Coscas G, Koenig F, Soubrane G. The pretear characteristics of pigment epithelial detachments. A study of 40 eyes. Arch Ophthalmol 1990;108:1687-1693.
8. Yeo JH, Marcus S, Murphy RP. Retinal pigment epithelial tears. Patterns and prognosis. Ophthalmology 1988;95:8-13.
9. Gass JD. Retinal pigment epithelial rip during krypton red laser photocoagulation. Am J Ophthalmol 1984;98:700-706.
10. Gelisken F, Inhoffen W, Partsch M, Schneider U, Kreissig I. Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization. Am J Ophthalmol 2001;131: 518-520.
11. Pece A, Introini U, Bottoni F, Brancato R. Acute retinal pigment epithelial tear after photodynamic therapy. Retina 2001;21:661-665.
12. Srivastava SK, Sternberg P Jr. Retinal pigment epithelial tear weeks following photodynamic therapy with verteporfin for choroidal neovascularization secondary to pathologic myopia. Retina 2002;22:669-771.
13. Arnold JJ, Blinder KJ, Bressler NM, et al; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group; Verteporfin in Photodynamic Therapy Study Group. Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3. Am J Ophthalmol 2004;137:683-696.
14. Goldstein M, Heilweil G, Barak A, Loewenstein A. Retinal pigment epithelial tear following photodynamic therapy for choroidal neovascularization secondary to AMD. Eye 2005; 19:1315-1324.
15. Michels S, Aue A, Simader C, Geitzenauer W, Sacu S, Schmidt-Erfurth U. Retinal pigment epithelium tears following verteporfin therapy combined with intravitreal triamcinolone. Am J Ophthalmol 2006;141:396-398.
16. Sutter FK, Kurz-Levin MM, Scherrer M, Barthelmes D, Fleischhauer JC, Helbig H. Intravitreal triamcinolone acetonide for serous retinal pigment epithelial detachments in exudative age-related macular degeneration. Klin Monatsbl Augenheilkd 2007;224:297-299.
17. Dhalla MS, Blinder KJ, Tewari A, Hariprasad SM, Apte RS. Retinal pigment epithelial tear following intravitreal pegaptanib sodium. Am J Ophthalmol 2006;141:752-754.
18. Singh RP, Sears JE. Retinal pigment epithelial tears after pegaptanib injection for exudative age-related macular degeneration. Am J Ophthalmol 2006;142:160-162.
19. Chang LK, Flaxel CJ, Lauer AK, Sarraf D. RPE tears after pegaptanib treatment in age-related macular degeneration. Retina 2007;27:857-863.
20. Carvounis PE, Kopel AC, Benz MS. Retinal pigment epithelium tears following ranibizumab for exudative age-related macular degeneration. Am J Ophthalmol 2007;143:504-505.
21. Bakri SJ, Kitzmann AS. Retinal pigment epithelial tear after intravitreal ranibizumab. Am J Ophthalmol 2007;143:505-507.
22. Chan CK, Lin SG. Retinal pigment epithelial tear after ranibizumab therapy for subfoveal fibrovascular pigment epithelial detachment. Eur J Ophthalmol 2007;17:674-676.
23. Meyer CH, Mennel S, Schmidt JC, Kroll P. Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularization secondary to age related macular degeneration. Br J Ophthalmol 2006;90:1207-1208.
24. Fung AE, Rosenfeld PJ, Reichel E. The international intravitreal bevacizumab safety survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 2006;90:1344-1349.
25. Shah CP, Hsu J, Garg SJ, Fischer DH, Kaiser R. Retinal pigment epithelial tear after intravitreal bevacizumab injection. Am J Ophthalmol 2006;142:1070-1072.
26. Spandau UH, Jonas JB. Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration. Am J Ophthalmol 2006;142:1068-1070.
27. Garg S, Brod R, Kim D, Lane RG, Maguire J, Fischer D. Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration. Clin Experiment Ophthalmol 2008;36:252-256.
28. Arias L, Caminal JM, Rubio M, Pujol O, Arruga J. Retinal pigment epithelial tears after intravitreal bevacizumab injection for predominantly classic choroidal neovascularization. Eur J Ophthalmol 2007;17:992-995.
29. Shaikh S, Olson JC, Richmond PP. Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration. Indian J Ophthalmol 2007; 55:470-472.
30. Cleary CA, Jungkim S, Ravikumar K, et al. Intravitreal bevacizumab in the treatment of neovascular age-related macular degeneration, 6- and 9-month results. Eye 2008;22:82-86.
31. Kook D, Wolf A, Neubauer AS, et al. Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD. Frequency and progress. Ophthalmologe [German] 2008;105: 158-164.
32. Ronan SM, Yoganathan P, Chien FY, et al. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina 2007;27:535-540.
33. Chan CK, Meyer CH, Gross JG, et al. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Retina 2007;27:541-551.
34. Chang LK, Sarraf D. Tears of the retinal pigment epithelium: an old problem in a new era. Retina 2007;27:523-534.
35. Leitritz M, Gelisken F, Inhoffen W, Voelker M, Ziemssen F. Can the risk of retinal pigment epithelium tears after bevacizumab treatment be predicted? An optical coherence tomography study. Eye 2008;22:1504-1507.
36. Chiang A, Chang LK, Yu F, Sarraf D. Predictors of anti- VEGF-associated retinal pigment epithelial tear using FA and OCT analysis. Retina 2008;28:1265-1269.
37. Coscas F, Coscas G, Souied E, Tick S, Soubrane G. Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 2007;144:592-599.
38. Gass JD. Radial chorioretinal folds. A sign of choroidal neovascularization. Arch Ophthalmol 1981;99:1016-1018.
39. Sato T, Iida T, Hagimura N, Kishi S. Correlation of optical coherence tomography with angiography in retinal pigment epithelial detachment associated with age-related macular degeneration. Retina 2004;24:910-914.
40. Giovannini A, Scassellati-Sforzolini B, Lafaut B, Edeling J, D'Altobrando E, De Laey JJ. Indocyanine green angiography of retinal pigment epithelial tears. Acta Ophthalmol Scand 1999;77:83-87.
41. Giovannini A, Amato G, Mariotti C, Scassellati-Sforzolini B. Optical coherence tomography in the assessment of retinal pigment epithelial tear. Retina 2000;20:37-40.
42. Pauleikoff D, Löffert D, Spital G, et al. Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 2002;240:533-538.
43. Moradian S, Ahmadieh H, Malihi M, Soheilian M, Dehghan MH, Azarmina M. Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2008;246:1699-1705.
44. Arevalo JF, Maia M, Flynn HW Jr, et al. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol 2008;92:213-216.